Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT

Peter Lang, MD, Michaela Döring, PD Dr. MD, Anne-Marie Lang, M.Sc., Patrick Schlegel, Dr. MD, Christian M. Seitz, Dr. MD, Robin Fischer, Dr. rer. nat., Ursula Holzer, PD Dr. MD, Ines Brecht, PD Dr. MD, Rupert Handgretinger, MD

Blood (2019) 134 (Supplement_1): 3255.

https://doi.org/10.1182/blood-2019-129654

Published: 2019

Journal Articles

Long Term Outcome and Late Effects in Patients Transplanted with Filgrastim-Mobilized Blood or Bone Marrow Treated in a Randomized Trial. A Study from the EBMT Late Effects Working Party

Birte Friedrichs, MD, Andre Tichelli, MD, Andrea Bacigalupo, MD, Nigel H. Russell, MD, Tapani Ruutu, MD, Meral Beksac, Gerard Socie, MD, Norbert Schmitz, MD

Blood (2008) 112 (11): 451.

https://doi.org/10.1182/blood.V112.11.451.451

Published: 2008

Journal Articles

Peripheral Blood Stem Cell Mobilisation with Pegfilgrastim Versus Filgrastim in Children and Adolescents

Peter Fritsch, Wolfgang Schwinger, Herwig Lackner, Petra Sovinz, Martin Benesch, Christian E. Urban

Blood (2008) 112 (11): 4314.

https://doi.org/10.1182/blood.V112.11.4314.4314

Published: 2008

Journal Articles

Target Marker Gene Expressions and the Possibility of Molecular Therapy for Children’s Brain Tumors.

Toshihisa Tsuruta, MD, PhD, Hitoshi Kanno, MD, PhD, Yasuo Aihara, MD, PhD, Takako Hamada, MD, PhD, Masako Sakauchi, MD, PhD, Makiko Osawa, MD, PhD, Emiko Wada, MD, PhD, Osami Kubo, MD, PhD, Tomokatsu Hori, MD, PhD, Hisaichi Fujii, MD, PhD

Blood (2006) 108 (11): 5468.

https://doi.org/10.1182/blood.V108.11.5468.5468

Published: 2006

Journal Articles

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Vassilios Papadakis, MD, PhD, Stefanos Papadhimitriou, MD, PhD, Anna Paisiou, MD, Agapi Parcharidou, MD,PhD, Natalia Tourkantoni, MD, George Paterakis, MD, PhD, Chrysoula Belesi, PhD, Constantina Sambani, PhD, Sophia Polychronopoulou, MD, PhD

Blood (2006) 108 (11): 4511.

https://doi.org/10.1182/blood.V108.11.4511.4511

Published: 2006

NARROW

Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT

Long Term Outcome and Late Effects in Patients Transplanted with Filgrastim-Mobilized Blood or Bone Marrow Treated in a Randomized Trial. A Study from the EBMT Late Effects Working Party

Peripheral Blood Stem Cell Mobilisation with Pegfilgrastim Versus Filgrastim in Children and Adolescents

Target Marker Gene Expressions and the Possibility of Molecular Therapy for Children’s Brain Tumors.

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT

Long Term Outcome and Late Effects in Patients Transplanted with Filgrastim-Mobilized Blood or Bone Marrow Treated in a Randomized Trial. A Study from the EBMT Late Effects Working Party

Peripheral Blood Stem Cell Mobilisation with Pegfilgrastim Versus Filgrastim in Children and Adolescents

Target Marker Gene Expressions and the Possibility of Molecular Therapy for Children’s Brain Tumors.

t(8;21) Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only